2 reports

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Antibiotic Resistance
  • Blood Disease
  • Cell Therapy
  • Therapy
  • Bristol-Myers Squibb Company

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antibiotic Resistance
  • Antifungal
  • United States
  • Product Initiative
  • SCYNEXIS, Inc.